Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomes
- 30 June 2011
- journal article
- Published by Elsevier BV in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 7 (3), 315-323
- https://doi.org/10.1016/j.nano.2010.10.004
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Enhanced Binding and Killing of Target Tumor Cells by Drug-Loaded Liposomes Modified with Tumor-Specific Phage Fusion Coat ProteinNanomedicine, 2010
- Liposomes targeted by fusion phage proteinsNanomedicine: Nanotechnology, Biology and Medicine, 2009
- A Novel Peptide Enhances Therapeutic Efficacy of Liposomal Anti-Cancer Drugs in Mice Models of Human Lung CancerPLOS ONE, 2009
- Gene Amplification and Overexpression of PRDM14 in Breast CancersCancer Research, 2007
- Polymer-based siRNA delivery: Perspectives on the fundamental and phenomenological distinctions from polymer-based DNA deliveryJournal of Controlled Release, 2007
- Display technologies: Application for the discovery of drug and gene delivery agentsAdvanced Drug Delivery Reviews, 2006
- Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic EfficacyCancer Research, 2006
- [Cell penetrating peptides enhance intracellular translocation and function of siRNA encapsulated in Pegylated liposomes].2006
- A library of organic landscapes on filamentous phage"Protein Engineering, Design and Selection", 1996
- Inserting foreign peptides into the major coat protein of bacteriophage M13FEBS Letters, 1992